Emcee Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 9.00 M
- Paid Up Capital ₹ 4.18 M
- Company Age 46 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.90 Cr
- Satisfied Charges ₹ 4.00 M
- Revenue Growth 34.22%
- Profit Growth 368.43%
- Ebitda 320.72%
- Net Worth 24.89%
- Total Assets 26.92%
About Emcee Pharmaceuticals
Emcee Pharmaceuticals Pvt Ltd (EPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 09 May 1978 and has a history of 46 years and nine months. Its registered office is in Nadia, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.00 M and a paid-up capital of Rs 4.18 M.
The company currently has active open charges totaling ₹3.90 Cr. The company has closed loans amounting to ₹4.00 M, as per Ministry of Corporate Affairs (MCA) records.
Shampa Moitra, Sudeep Basu, and Utpal Moitra serve as directors at the Company.
Company Details
- Location
Nadia, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239WB1978PTC031482
- Company No.
031482
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 May 1978
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Emcee Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shampa Moitra  | Director | 05-Sep-2003 | Current |
| Sudeep Basu | Director | 05-Sep-2003 | Current |
| Utpal Moitra | Director | 17-Feb-1992 | Current |
Financial Performance of Emcee Pharmaceuticals.
Emcee Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 34.22% increase. The company also saw a substantial improvement in profitability, with a 368.43% increase in profit. The company's net worth Soared by an impressive increase of 24.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Emcee Pharmaceuticals?
In 2021, Emcee Pharmaceuticals had a public holding of 3.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹39.00 M
₹4.00 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 3.90 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Sep 2005 | State Bank Of India | ₹3.00 Cr | Open |
| 18 Mar 2004 | State Bank Of India | ₹9.00 M | Open |
| 17 Mar 2005 | Small Industrial Development Bank Of India | ₹4.00 M | Satisfied |
How Many Employees Work at Emcee Pharmaceuticals?
Emcee Pharmaceuticals has a workforce of 223 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Emcee Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emcee Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.